Association of sickle cell trait with adverse pregnancy outcomes in a population-based cohort.


Journal

Acta obstetricia et gynecologica Scandinavica
ISSN: 1600-0412
Titre abrégé: Acta Obstet Gynecol Scand
Pays: United States
ID NLM: 0370343

Informations de publication

Date de publication:
08 2023
Historique:
revised: 26 05 2023
received: 25 04 2023
accepted: 27 05 2023
medline: 31 7 2023
pubmed: 26 6 2023
entrez: 26 6 2023
Statut: ppublish

Résumé

Sickle cell trait (SCT) is common in African descendants. Its association with several adverse pregnancy outcomes (APOs) has been reported but remains inconsistent. The objectives of this study are to test associations of SCT with APOs in non-Hispanic Black women, including (1) validate the associations of SCT with previously reported APOs, (2) test novel associations of SCT with broad spectrum of APOs, and (3) estimate the attributable risk of SCT for implicated APOs. This is a retrospective analysis of a prospectively designed population-based cohort. Women/participants were self-reported non-Hispanic Black women from the UK Biobank (UKB). SCT status was determined based on heterozygous Glu6Val in the HBB gene. Several APOs were studied, including four previously reported SCT-associated APOs (preeclampsia, bacteriuria, pregnancy loss, and preterm delivery), and broad conditions related to pregnancy, childbirth, and the puerperium. APOs were curated by experts' peer review and consensus processes. Associations of SCT with APOs were tested by estimating its relative risk and 95% confidence interval (95% CI), adjusting for number of live births and age at first birth. Attributable risk proportion (ARP) and population attributable risk proportion (PARP) of SCT to APOs were estimated. Among the 4057 self-reported non-Hispanic Black women with pregnancy records in the UKB, 581 (14.32%) were SCT carriers. For four previously reported SCT-associated APOs, two were confirmed at a nominal P < 0.05; relative risk (RR) was 2.39 (95% CI 1.09-5.23) for preeclampsia, and 4.85 (95% CI 1.77-13.27) for bacteriuria. SCT contributed substantially to these two APOs among SCT carriers, with attributable risk proportion estimated at 61.00% and 68.96% for preeclampsia and bacteriuria, respectively. SCT also contributed substantially to these two APOs in the population (self-reported Black UK women), with population attributable risk proportion estimated at 18.30% and 24.14% for preeclampsia and bacteriuria, respectively. In addition, novel associations were found for seven other APOs (nominal P < 0.05). SCT is significantly associated with APOs in this study and contributes substantially to APOs among self-reported Black women in the UK. Confirmation of these findings in independent study populations is required.

Identifiants

pubmed: 37358249
doi: 10.1111/aogs.14622
pmc: PMC10378004
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1100-1105

Informations de copyright

© 2023 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).

Références

Obstet Gynecol. 2018 Feb;131(2):328-335
pubmed: 29324613
AJP Rep. 2019 Oct;9(4):e346-e352
pubmed: 31723455
JAMA. 2014 Apr 16;311(15):1495-6
pubmed: 24604073
Am J Obstet Gynecol. 2006 Jun;194(6):1604-8
pubmed: 16635469
Am J Obstet Gynecol. 1997 Aug;177(2):425-8
pubmed: 9290462
N Engl J Med. 1979 May 3;300(18):1001-5
pubmed: 431593
Am J Perinatol. 2003 Jan;20(1):41-8
pubmed: 12638080
Int J Gynaecol Obstet. 1990 Sep;33(1):19-21
pubmed: 1974527
Am J Hematol. 2018 Oct;93(10):1227-1235
pubmed: 30033564
Am Heart J. 2021 Dec;242:92-102
pubmed: 34481757
Am J Med. 2022 Aug;135(8):e279-e287
pubmed: 35461807
Br J Haematol. 2015 Apr;169(1):129-37
pubmed: 25522142
Lancet. 2013 Jan 12;381(9861):142-51
pubmed: 23103089
Trans R Soc Trop Med Hyg. 1954 Jul;48(4):312-8
pubmed: 13187561
Nature. 2018 Oct;562(7726):203-209
pubmed: 30305743
J Epidemiol Community Health. 2002 Aug;56(8):606-10
pubmed: 12118052
Am J Med. 2009 Jun;122(6):507-12
pubmed: 19393983
JAMA. 2022 Feb 1;327(5):421-422
pubmed: 35024771
Micromachines (Basel). 2021 May 05;12(5):
pubmed: 34063111
Acta Obstet Gynecol Scand. 2023 Aug;102(8):1100-1105
pubmed: 37358249
Lancet. 2010 Dec 11;376(9757):2018-31
pubmed: 21131035
JAMA. 1972 Sep 18;221(12):1404-5
pubmed: 5068558
Obstet Gynecol. 2018 Jul;132(1):e44-e52
pubmed: 29939940
Haematologica. 2019 Jun;104(6):1106-1111
pubmed: 31097635
Hematology Am Soc Hematol Educ Program. 2015;2015:160-7
pubmed: 26637716
Br J Haematol. 2020 Aug;190(3):328-335
pubmed: 32064587

Auteurs

Joseph Hulsizer (J)

Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois, USA.

Andrew S Rifkin (AS)

Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois, USA.

Zhuqing Shi (Z)

Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois, USA.

Jun Wei (J)

Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois, USA.

S Lilly Zheng (SL)

Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois, USA.

Brian T Helfand (BT)

Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois, USA.
Department of Surgery, NorthShore University HealthSystem, Evanston, Illinois, USA.
Department of Surgery, University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA.

Jessica Morgan (J)

Department of Obstetrics and Gynecology, NorthShore University HealthSystem, Evanston, Illinois, USA.

David W Ouyang (DW)

Department of Obstetrics and Gynecology, NorthShore University HealthSystem, Evanston, Illinois, USA.

Michael S Caplan (MS)

Department of Pediatrics, NorthShore University HealthSystem, Evanston, Illinois, USA.
Department of Pediatrics, University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA.

Jianfeng Xu (J)

Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois, USA.
Department of Surgery, NorthShore University HealthSystem, Evanston, Illinois, USA.
Department of Surgery, University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH